Yang, M., Schell, M. J., Loboda, A., Nebozhyn, M. V., Li, J., Teer, J. K., . . . Yeatman, T. J. (2019). Repurposing EGFR inhibitor utility in colorectal cancer in mutant APC and TP53 subpopulations. Cancer Epidemiol Biomarkers Prev.
Chicago Style CitationYang, Mingli, Michael J. Schell, Andrey Loboda, Michael V. Nebozhyn, Jiannong Li, Jamie K. Teer, W. Jack Pledger, and Timothy J. Yeatman. "Repurposing EGFR Inhibitor Utility in Colorectal Cancer in Mutant APC and TP53 subpopulations." Cancer Epidemiol Biomarkers Prev 2019.
MLA CitationYang, Mingli, et al. "Repurposing EGFR Inhibitor Utility in Colorectal Cancer in Mutant APC and TP53 subpopulations." Cancer Epidemiol Biomarkers Prev 2019.
Warning: These citations may not always be 100% accurate.